Colin Walsh

Managing Director - Life Sciences Investing at Goldman Sachs

Colin Walsh is a highly experienced recruiter and co-founder of Crucible Recruitment, a company committed to providing outstanding service to both their clients and candidates. With nearly two decades of working in recruitment, Colin still maintains a hands-on approach when it comes to finding the right candidate for a job. Prior to founding Crucible Recruitment, Colin served as Director at New Life Recruitment and Aardvark Swift. Colin is a graduate of Sheffield Hallam University and Bolton School.

Experience

Managing Director - Life Sciences Investing at Goldman Sachs (September 2023 - Present)

Partner at Qiming Venture Partners USA (April 2019 - October 2023); Vice President at NanoDimension (September 2017 - April 2019), Board Member at Abdera Therapeutics, Entact Bio, Element Science, Inc., Korro Bio, Inc., Elevation Oncology; Board Observer at Ventyx Biosciences, Icosavax, Inc.

Education

PhD in Bioengineering from University of California, San Francisco and University of California, Berkeley (2007 - 2012); B.S in Chemical Engineering, Biochemistry from University of Massachusetts, Amherst (2003 - 2007); Certificate in Management of Technology from University of California, Berkeley - Walter A. Haas School of Business (2007 - 2012)